D-210-2013 Class III Terminated
FDA drug recall D-210-2013 was initiated by Novartis Consumer Health on Mar 7, 2013 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Lot and/or Exp Date. The lot number and/or expiration date may be illegible. The recall status is terminated (terminated Nov 26, 2014). Affected quantity: 44,604/ .5-fl. oz. bottles and 439,452 /1-fl. oz. bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 27, 2013
- Initiation Date
- Mar 7, 2013
- Termination Date
- Nov 26, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 44,604/ .5-fl. oz. bottles and 439,452 /1-fl. oz. bottles
Product description
4 way Nasal Decongestant Menthol Nasal Spray, containing phenylephrine hydrochloride 1%, a) 1/2-fl. oz. bottles (NDC 0067-2087-05) b) 1-fl. oz. bottles (NDC 0067-2087-01), OTC. Distributed by Novartis Consumer Health, Inc., Parsippany, NJ 07054.
Reason for recall
Labeling: Incorrect or Missing Lot and/or Exp Date. The lot number and/or expiration date may be illegible.
Distribution pattern
Nationwide and Panama
Code information
Lot #: a) 10120598, Exp 7/13; 10127563, Exp 11/13; b) 10107920, 10108362, 10108363, 10108364, 10109881, 10110017, 10110018, 10110019, 10110020, 10120730, 10120731, 10120732, 10120733, 10120734, 10120735, 10120736, 10127556, 10127557, 10127558, and 10127559, Exp 3/13 to 10/13.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-210-2013
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026